Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 9.81% is 13% below its 5-year average of 11.21%, near the low end of its 5-year range (-0.15%–33.17%).
11.19% above its 12-month average of 8.82%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
9.81%
NET PROFIT MARGIN AVG TTM
8.82%
NET PROFIT MARGIN AVG 3Y
8.07%
NET PROFIT MARGIN AVG 5Y
11.21%
NET PROFIT MARGIN AVG 10Y
15.70%
NET PROFIT MARGIN AVG 15Y
18.55%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+11.19%
CURRENT VS 3Y AVG
+21.56%
CURRENT VS 5Y AVG
-12.50%
CURRENT VS 10Y AVG
-37.53%
CURRENT VS 15Y AVG
-47.11%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.98%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+9.24%
vs the sector median at left
Market Cap
$367.24B
Net Profit Margin
4.78%
TTM Avg
27.40%
3Y Avg
19.98%
5Y Avg
20.62%
Market Cap
$345.60B
Net Profit Margin
20.33%
TTM Avg
16.80%
3Y Avg
17.87%
5Y Avg
19.70%
Market Cap
$345.58B
Net Profit Margin
3.14%
TTM Avg
3.15%
3Y Avg
4.63%
5Y Avg
5.09%
Market Cap
$246.27B
Net Profit Margin
17.02%
TTM Avg
15.23%
3Y Avg
12.72%
5Y Avg
10.53%
Market Cap
$649.81B
Net Profit Margin
21.48%
TTM Avg
22.15%
3Y Avg
27.00%
5Y Avg
25.39%
Market Cap
$223.06B
Net Profit Margin
15.06%
TTM Avg
14.95%
3Y Avg
14.84%
5Y Avg
16.47%
Market Cap
$200.85B
Net Profit Margin
35.33%
TTM Avg
33.96%
3Y Avg
33.83%
5Y Avg
33.74%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | $442.18B | 9.81% | 8.82% | 8.07% | 11.21% |
| Merck & Co., Inc. (MRK)vs › | $367.24B | 4.78% | 27.40% | 19.98% | 20.62% |
| Roche Holding AG (RHHBY)vs › | $345.60B | 20.33% | 16.80% | 17.87% | 19.70% |
| UnitedHealth Group Incorporated (UNH)vs › | $345.58B | 3.14% | 3.15% | 4.63% | 5.09% |
| AstraZeneca PLC (AZN)vs › | $246.27B | 17.02% | 15.23% | 12.72% | 10.53% |
| Johnson & Johnson (JNJ)vs › | $649.81B | 21.48% | 22.15% | 27.00% | 25.39% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $223.06B | 15.06% | 14.95% | 14.84% | 16.47% |
| Amgen Inc. (AMGN)vs › | $213.06B | 22.93% | 16.61% | 20.49% | 22.20% |
| Novo Nordisk A/S (NVO)vs › | $200.85B | 35.33% | 33.96% | 33.83% | 33.74% |
| Abbott Laboratories (ABT)vs › | $183.96B | 11.65% | 23.34% | 19.20% | 17.71% |
Operating Margin
29.3%
Net Profit Margin
9.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 21.27% |
| 2026-03-31 | 4.66% |
| 2025-12-31 | 10.93% |
| 2025-09-30 | 1.18% |
| 2025-06-30 | 6.08% |
| 2025-03-31 | 9.64% |
| 2024-12-31 | -0.15% |
| 2024-09-30 | 10.80% |
| 2024-06-30 | 9.47% |
| 2024-03-31 | 11.12% |
| 2023-12-31 | 5.75% |
| 2023-09-30 | 12.77% |
| 2023-06-30 | 14.60% |
| 2023-03-31 | 1.96% |
| 2022-12-31 | 16.35% |
| 2022-09-30 | 26.66% |
| 2022-06-30 | 6.34% |
| 2022-03-31 | 33.17% |
| 2021-12-31 | 27.17% |
| 2021-09-30 | 22.17% |
| 2021-06-30 | 5.49% |
| 2021-03-31 | 27.31% |
| 2020-12-31 | 0.26% |
| 2020-09-30 | 17.89% |
| 2020-06-30 | -7.08% |
| 2020-03-31 | 34.92% |
| 2019-12-31 | 32.18% |
| 2019-09-30 | 22.22% |
| 2019-06-30 | 8.98% |
| 2019-03-31 | 31.37% |
| 2018-12-31 | -21.99% |
| 2018-09-30 | 33.35% |
| 2018-06-30 | 23.96% |
| 2018-03-31 | 35.08% |
| 2017-12-31 | 0.67% |
| 2017-09-30 | 23.32% |
| 2017-06-30 | 27.58% |
| 2017-03-31 | 26.17% |
| 2016-12-31 | 20.47% |
| 2016-09-30 | 24.84% |
| 2016-06-30 | 24.95% |
| 2016-03-31 | 22.73% |
| 2015-12-31 | 23.70% |
| 2015-09-30 | 20.84% |
| 2015-06-30 | 24.95% |
| 2015-03-31 | 20.28% |
| 2014-12-31 | -14.86% |
| 2014-09-30 | 10.08% |
| 2014-06-30 | 22.29% |
| 2014-03-31 | 21.48% |
| 2013-12-31 | 22.07% |
| 2013-09-30 | 20.70% |
| 2013-06-30 | 22.76% |
| 2013-03-31 | 22.36% |
| 2012-12-31 | 29.58% |
| 2012-09-30 | 35.16% |
| 2012-06-30 | 28.20% |
| 2012-03-31 | 21.16% |
| 2011-12-31 | 23.80% |
| 2011-09-30 | 0.28% |
| 2011-06-30 | 36.03% |
| 2011-03-31 | 18.56% |
